187 related articles for article (PubMed ID: 30145321)
21. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test.
Pałucha-Poniewiera A; Podkowa K; Lenda T; Pilc A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):155-161. PubMed ID: 28647535
[TBL] [Abstract][Full Text] [Related]
22. Off-target potential of AMN082 on sleep EEG and related physiological variables: Evidence from mGluR7 (-/-) mice.
Ahnaou A; Raeyemaekers L; Huysmans H; Drinkenburg WHIM
Behav Brain Res; 2016 Sep; 311():287-297. PubMed ID: 27211063
[TBL] [Abstract][Full Text] [Related]
23. The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice.
Bahi A
Pharmacol Biochem Behav; 2012 Apr; 101(2):193-200. PubMed ID: 22269296
[TBL] [Abstract][Full Text] [Related]
24. The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?
Sukoff Rizzo SJ; Leonard SK; Gilbert A; Dollings P; Smith DL; Zhang MY; Di L; Platt BJ; Neal S; Dwyer JM; Bender CN; Zhang J; Lock T; Kowal D; Kramer A; Randall A; Huselton C; Vishwanathan K; Tse SY; Butera J; Ring RH; Rosenzweig-Lipson S; Hughes ZA; Dunlop J
J Pharmacol Exp Ther; 2011 Jul; 338(1):345-52. PubMed ID: 21508084
[TBL] [Abstract][Full Text] [Related]
25. Positive allosteric modulation of mGlu7 receptors by AMN082 affects sleep and wakefulness in the rat.
Cavas M; Scesa G; Navarro JF
Pharmacol Biochem Behav; 2013 Feb; 103(4):756-63. PubMed ID: 23262401
[TBL] [Abstract][Full Text] [Related]
26. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
27. A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse.
Julio-Pieper M; Hyland NP; Bravo JA; Dinan TG; Cryan JF
Br J Pharmacol; 2010 May; 160(2):367-75. PubMed ID: 20423346
[TBL] [Abstract][Full Text] [Related]
28. Combined treatment of scopolamine and group III mGluR antagonist, CPPG, exerts antidepressant activity without affecting anxiety-related behaviors.
Ebrahimi-Ghiri M; Khakpai F; Zarrindast MR
Physiol Behav; 2020 Oct; 224():113034. PubMed ID: 32603748
[TBL] [Abstract][Full Text] [Related]
29. Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.
Li X; Xi ZX; Markou A
Neuropharmacology; 2013 Mar; 66():12-23. PubMed ID: 22546614
[TBL] [Abstract][Full Text] [Related]
30. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
[TBL] [Abstract][Full Text] [Related]
31. Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice.
Poleszak E; Wośko S; Serefko A; Szopa A; Wlaź A; Szewczyk B; Nowak G; Wlaź P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():29-35. PubMed ID: 23774195
[TBL] [Abstract][Full Text] [Related]
32. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.
Kłak K; Pałucha A; Brański P; Sowa M; Pilc A
Amino Acids; 2007 Feb; 32(2):169-72. PubMed ID: 16868652
[TBL] [Abstract][Full Text] [Related]
33. Computationally Guided Identification of Allosteric Agonists of the Metabotropic Glutamate 7 Receptor.
Cid JM; Lavreysen H; Tresadern G; Pérez-Benito L; Tovar F; Fontana A; Trabanco AA
ACS Chem Neurosci; 2019 Mar; 10(3):1043-1054. PubMed ID: 30216043
[TBL] [Abstract][Full Text] [Related]
34. The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat.
Dolan S; Gunn MD; Biddlestone L; Nolan AM
Behav Pharmacol; 2009 Oct; 20(7):596-604. PubMed ID: 19667973
[TBL] [Abstract][Full Text] [Related]
35. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Acher F; Brański P; Pilc A
Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068
[TBL] [Abstract][Full Text] [Related]
36. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
[TBL] [Abstract][Full Text] [Related]
37. Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice.
Dobi A; Sartori SB; Busti D; Van der Putten H; Singewald N; Shigemoto R; Ferraguti F
Neuropharmacology; 2013 Mar; 66():274-89. PubMed ID: 22643400
[TBL] [Abstract][Full Text] [Related]
38. Additive interaction between scopolamine and nitric oxide agents on immobility in the forced swim test but not exploratory activity in the hole-board.
Nasehi M; Mohammadi-Mahdiabadi-Hasani MH; Ebrahimi-Ghiri M; Zarrindast MR
Psychopharmacology (Berl); 2019 Nov; 236(11):3353-3362. PubMed ID: 31175384
[TBL] [Abstract][Full Text] [Related]
39. M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine.
Witkin JM; Overshiner C; Li X; Catlow JT; Wishart GN; Schober DA; Heinz BA; Nikolayev A; Tolstikov VV; Anderson WH; Higgs RE; Kuo MS; Felder CC
J Pharmacol Exp Ther; 2014 Nov; 351(2):448-56. PubMed ID: 25187432
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice.
Petryshen TL; Lewis MC; Dennehy KA; Garza JC; Fava M
Neurosci Lett; 2016 May; 620():70-3. PubMed ID: 27033002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
